1. Home
  2. MRCC vs INO Comparison

MRCC vs INO Comparison

Compare MRCC & INO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Monroe Capital Corporation

MRCC

Monroe Capital Corporation

HOLD

Current Price

$5.08

Market Cap

100.1M

Sector

Finance

ML Signal

HOLD

Logo Inovio Pharmaceuticals Inc.

INO

Inovio Pharmaceuticals Inc.

HOLD

Current Price

$1.35

Market Cap

114.0M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
MRCC
INO
Founded
2011
1979
Country
United States
United States
Employees
N/A
N/A
Industry
Investment Managers
Medical/Dental Instruments
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
100.1M
114.0M
IPO Year
2011
1999

Fundamental Metrics

Financial Performance
Metric
MRCC
INO
Price
$5.08
$1.35
Analyst Decision
Buy
Analyst Count
0
4
Target Price
N/A
$6.75
AVG Volume (30 Days)
124.8K
3.4M
Earning Date
05-06-2026
05-08-2026
Dividend Yield
7.09%
N/A
EPS Growth
N/A
54.18
EPS
N/A
N/A
Revenue
N/A
$42,220,086.00
Revenue This Year
N/A
$20,156.19
Revenue Next Year
N/A
$421.95
P/E Ratio
N/A
N/A
Revenue Growth
N/A
19.37
52 Week Low
$4.11
$1.03
52 Week High
$7.76
$2.86

Technical Indicators

Market Signals
Indicator
MRCC
INO
Relative Strength Index (RSI) 52.95 55.87
Support Level $4.44 $1.03
Resistance Level $6.77 $1.79
Average True Range (ATR) 0.24 0.16
MACD 0.09 0.01
Stochastic Oscillator 71.19 34.85

Price Performance

Historical Comparison
MRCC
INO

About MRCC Monroe Capital Corporation

Monroe Capital Corp is a speciality finance company focused on providing financing to lower middle-market companies, in the United States and Canada. The company provides customized financing solutions focused on senior, unitranche, and junior secured debt and unsecured subordinated debt and equity, including equity co-investments in preferred and common stock and warrants. Its investment objective is to maximize the total return to its stockholders in the form of current income and capital appreciation through investment in senior secured, unitranche secured and junior secured debt and, to a lesser extent, unsecured subordinated debt and equity investments.

About INO Inovio Pharmaceuticals Inc.

Inovio Pharmaceuticals Inc is a United States-based biotechnology company. The company is focused on developing and commercializing DNA medicines to help treat and protect people from HPV-associated diseases, cancer and infectious diseases. The company is engaged in gene therapy, where its immunotherapy platform consists of DNA-based immunotherapy and electroporation delivery technologies.

Share on Social Networks: